MedTrace Logo

Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants

NCT00899457 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2014-06-24

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood, urine, sputum, mouth cells, and bronchial tissue from healthy participants in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors learn more about the development of cancer.

PURPOSE: This laboratory study is looking for molecular markers in predicting lung cancer development using tissue samples from healthy participants.

Conditions

Interventions

GENETIC

proteomic profiling

Collection of tissue, blood, urine, mouth cells, spit, nasal airway cells and breath

OTHER

biologic sample preservation procedure

Collection of tissue, blood, urine, mouth cells, spit, nasal airway cells and breath

OTHER

laboratory biomarker analysis

Collection of tissue, blood, urine, mouth cells, spit, nasal airway cells and breath

PROCEDURE

bronchoscopy

Collection of breath condensate.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt-Ingram Cancer Center

    lead OTHER

Principal Investigators

  • Pierre P. Massion, MD · Vanderbilt-Ingram Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00899457 on ClinicalTrials.gov